388 related articles for article (PubMed ID: 9541420)
1. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
[TBL] [Abstract][Full Text] [Related]
2. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
3. Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment.
Utili R; Zampino R; De Vivo F; Maiello C; Andreana A; Mormone G; Marra C; Tripodi MF; Sarnataro G; Cione P; Cuccurullo S; Cotrufo M
Clin Transplant; 2000 Aug; 14(4 Pt 1):282-6. PubMed ID: 10945197
[TBL] [Abstract][Full Text] [Related]
4. [Curative treatment of invasive aspergillosis].
Dupont B
Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Prince RA; Chi J; Kontoyiannis DP
Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
Denning DW; Hall L; Jackson M; Hollis S
Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism.
Schaffner A; Böhler A
Mycoses; 1993; 36(11-12):421-4. PubMed ID: 7935575
[TBL] [Abstract][Full Text] [Related]
9. Disseminated invasive aspergillosis in an apparently immunocompetent host.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
[TBL] [Abstract][Full Text] [Related]
10. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
[TBL] [Abstract][Full Text] [Related]
11. [Case of pulmonary aspergillosis successfully treated with itraconazole].
Watanabe T; Kuriyama K; Kamei K
Jpn J Antibiot; 2000 Feb; 53(2):103-6; discussion 106-7. PubMed ID: 10896537
[No Abstract] [Full Text] [Related]
12. Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease.
van 't Wout JW; Raven EJ; van der Meer JW
J Infect; 1990 Mar; 20(2):147-50. PubMed ID: 2156938
[TBL] [Abstract][Full Text] [Related]
13. [Invasive pulmonary aspergillosis caused by Aspergillus ochraceus].
Wierzbicka M; Podsiadło B; Janczarski M
Pneumonol Alergol Pol; 1997; 65(3-4):254-60. PubMed ID: 9489424
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous reversibility of "pleural thickening" in a patient with semi-invasive pulmonary aspergillosis: radiographic and CT findings.
Franquet T; Giménez A; Cremades R; Domingo P; Plaza V
Eur Radiol; 2000; 10(5):722-4. PubMed ID: 10823622
[TBL] [Abstract][Full Text] [Related]
15. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
16. Experience with itraconazole in cryptococcosis and aspergillosis.
Viviani MA; Tortorano AM; Langer M; Almaviva M; Negri C; Cristina S; Scoccia S; De Maria R; Fiocchi R; Ferrazzi P
J Infect; 1989 Mar; 18(2):151-65. PubMed ID: 2540243
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary aspergillosis in an immunocompetent patient.
Ko JP; Kim DH; Shepard JA
J Thorac Imaging; 2002 Jan; 17(1):70-3. PubMed ID: 11828215
[TBL] [Abstract][Full Text] [Related]
18. [Curative antifungal treatment of invasive pulmonary aspergillosis].
Andrès E; Courouau F; Kurtz JE; Limacher JM; Quoix E
Rev Pneumol Clin; 1995; 51(4):228-31. PubMed ID: 7501940
[TBL] [Abstract][Full Text] [Related]
19. In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.
Manavathu EK; Dimmock JR; Vashishtha SC; Cutright J; Chandrasekar PH
J Antimicrob Chemother; 1998 Nov; 42(5):585-90. PubMed ID: 9848441
[TBL] [Abstract][Full Text] [Related]
20. [Invasive aspergillosis in patients infected by the human immunodeficiency virus].
Rodríguez-Arrondo F; Iribarren JA; Arrizabalaga J; Grocin AI; von Wichmann MA; Garde C
Enferm Infecc Microbiol Clin; 1991 Oct; 9(8):477-83. PubMed ID: 1805949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
